News

Explore Latest News .

Find all the latest news on Paul Peter Tak, as well as a comprehensive list of his past interviews and features. Paul Peter’s work in immunology and the pharmaceutical industry has led him to be featured in both business and medicine specific publications.

During his time at GlaxoSmithKline, Paul Peter gave a number of interviews and briefs, including one with the Biochemical Society in 2017. In this insightful interview, Paul Peter outlined what the GSK Immunology Network was and its impact on this important area of research.

In December 2020, Paul Peter Tak spoke with Eleanor Malone, from Scrip, about the work Candel Therapeutics was undertaking in the field of cancer immunotherapy and the companies ambitious future. Paul Peter has also had more broad discussions around his career and what inspires him, such as his interview with Stephanie Sutton for The Medicine Maker, in 2020.   

Carrie Cox joins the Candel team and lead our Board of Directors

We are delighted to have Carrie Cox join the Candel team and lead our Board of Directors. Her strategic insights will be key as we advance our late stage pipeline of agents with the potential to bec…

Prof Paul Peter Tak: Rheumatology, Real Impact and Comfort Zones

In this week’s podcast episode, Professor Paul Peter Tak joins us as we delve into the multifaceted facets of his life, starting from his formative years growing up in the Netherlands. Professo…

The Story of Flagship Pioneering and The Future of Medicines

James is delighted to be joined by the accomplished Dr. Paul-Peter Tak, currently serving as the Venture Partner at Flagship Pioneering and holding the esteemed position of CEO at Kintai Therapeutic…

Careers in Discovery

Embark on an enriching exploration into the dynamic realms of Pharma and Biotech with “Careers in Discovery” – a captivating series that serves as your exclusive window into the captivating world of…

Listen Notes: Paul-Peter Tak, Academic, business leader and biotech entrepreneur

In this engaging episode, Dr. Paul-Peter Tak joins Monica Westley for an insightful conversation delving into his innovative ideas within the realm of type 1 diabetes. As an esteemed immunologist, a…

Podomatic: Paul-Peter Tak

In biotech, DR. PAUL-PETER TAK, the CEO of Kintai Therapeutics gives us a bigger picture of our gut – it’s not just your microbiome that plays a significant role in the recovery from illness. Lis…
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.